8-K/A: Flexible Solutions Secures Major Food Grade Manufacturing Contract

Flexible Solutions International's subsidiary, Nanochem Solutions, Inc., has entered into a new five-year food grade manufacturing and supply agreement with an estimated annual revenue of $6.5 million to $13 million.

Summary

• Flexible Solutions International Inc. (FSI) subsidiary, Nanochem Solutions, Inc. (NCS), has signed a Manufacturing Services and Supply Agreement with an unnamed customer.
• The agreement, effective August 7, 2025, designates NCS as a non-exclusive supplier of ingredients and inputs for the customer's human nutrition and use products.
• The contract is projected to generate estimated annual revenue between $6.5 million and $13 million for NCS.
• Limited production will commence immediately, with a rapid scale-up to full production without requiring additional equipment or capital improvements.
• The initial term of the agreement is five years, with automatic one-year renewals thereafter, unless terminated with 90 days' written notice.
• The customer retains all intellectual property rights related to the products and work performed under the agreement.
• NCS, FSI, and their affiliates are subject to a non-compete clause regarding specific (Omitted) products during the term of the agreement.

Sentiment

Score: 8

Explanation: The new contract represents a significant, stable revenue stream with no additional capital expenditure required, indicating strong operational leverage and immediate positive financial impact. While the non-exclusive nature and IP ownership by the customer are minor drawbacks, the overall financial benefit and long-term commitment are highly positive for the company's outlook.

Positives

• Secured a new food grade manufacturing contract, providing a stable revenue stream for NCS.
• Estimated annual revenue of $6.5 million to $13 million is a significant financial boost for NCS.
• No additional capital expenditure is required for equipment or improvements to reach full production, indicating efficient utilization of existing assets and strong operational leverage.
• The agreement has a substantial initial term of five years with automatic renewals, offering long-term revenue visibility and stability.
• The customer is responsible for maintaining necessary governmental and statutory permits, licenses, and registrations for the products, reducing NCS's administrative burden in this area.
• Customer may negotiate with vendors on behalf of NCS or directly order raw materials, potentially optimizing supply chain costs and ensuring material availability.

Negatives

• The customer is a non-exclusive supplier, meaning they can source products from other manufacturers, potentially limiting NCS's market share with this customer.
• Customer forecasts are non-binding estimates and do not constitute a commitment to purchase specific quantities, introducing some revenue variability.
• NCS has limited grounds to reject purchase orders (only for failure to pay or inconsistency with price/volume terms), which could constrain operational flexibility.
• Customer retains all intellectual property rights related to the products, limiting NCS's ability to independently commercialize them or leverage the IP for other ventures.
• NCS, FSI, and their affiliates are subject to a non-compete clause, restricting their ability to manufacture certain (Omitted) products, which could limit future business opportunities.
• NCS is required to maintain specific insurance policies and may need to procure additional coverages requested by the customer, with costs potentially passed through, adding to overhead.

Risks

• **Customer Concentration**: Potential over-reliance on a single, albeit unnamed, customer for a significant portion of NCS's revenue.
• **Non-Binding Forecasts**: Customer forecasts are estimates and not binding, which could lead to variability in actual orders and revenue, impacting production planning.
• **Product Liability**: NCS warrants products meet specifications and are free from defects, exposing it to potential liability for non-conforming products and associated damages.
• **Regulatory Compliance**: NCS must ensure all manufacturing processes and products comply with FDA food regulations and all applicable federal, state, and local laws, rules, regulations, and ordinances, which carries inherent compliance risks.
• **Supply Chain Disruptions**: While customer can assist, NCS bears the primary responsibility for ordering raw materials, making it vulnerable to supply chain disruptions or price volatility.
• **Intellectual Property Restrictions**: NCS has no rights to commercialize the products or use the intellectual property, limiting future independent product development or market expansion in this specific area.
• **Non-Compete Clause**: Restrictions on manufacturing certain products could limit future business opportunities and market reach for NCS and FSI.
• **Termination Risk**: The agreement can be terminated under various conditions, including material breach, multiple breaches by NCS, insolvency, or for convenience with six months' notice, posing a risk to long-term revenue.
• **Force Majeure**: Prolonged force majeure events impacting NCS (e.g., for 30 consecutive days or 45 days in any 12-month period) could lead to customer termination of the agreement.

Future Outlook

Limited production under the new food grade contract will begin immediately, with plans to scale up to the estimated annual revenue of $6.5 million to $13 million as quickly as possible. No additional equipment or capital improvements are needed to achieve full production, suggesting a rapid and efficient ramp-up.

Management Comments

• The Company recently entered into a new food grade contract for its Illinois plant with estimated revenue between $6.5 million and $13 million per year.
• Limited production will begin immediately and scale up to the revenue estimates as quickly as possible.
• No additional equipment or capital improvements are needed to begin, or to reach, full production.

Industry Context

This contract positions Flexible Solutions International's subsidiary, Nanochem Solutions, Inc., as a key supplier in the human nutrition and food ingredients sector. The demand for specialized ingredients and contract manufacturing services in this industry remains robust, driven by evolving consumer health trends, increasing regulatory scrutiny, and the need for reliable, compliant supply chains. The non-exclusive nature of the agreement is common in contract manufacturing, allowing customers flexibility while providing a base load for manufacturers. The emphasis on FDA compliance and stringent quality assurance protocols reflects the highly regulated and quality-sensitive environment of the food and human use product market.

Comparison to Industry Standards

• NA

Stakeholder Impact

• **Shareholders**: Expected positive impact due to a new, significant, and stable revenue stream, improved financial outlook, and efficient use of existing capital without new CapEx.
• **Employees (NCS)**: Potential for increased workload and possibly additional staffing, including a dedicated Production Manager and mechanical engineer, as per customer request, which could lead to job creation.
• **Customers (of NCS)**: The unnamed customer benefits from a reliable, FDA-compliant, and quality-assured supplier for critical ingredients for their human use products.
• **Suppliers (to NCS)**: Potential for increased orders of raw materials and ingredients due to higher production volumes, fostering stronger supplier relationships.

Next Steps

• Limited production will begin immediately at NCS's Illinois plant.
• Production will scale up to the estimated annual revenue targets as quickly as possible.
• The customer is to provide the first quarterly forecast following the initial validation run.
• NCS must deliver proposed quality assurance protocols and operating parameters within 90 days of agreement execution, or at least 30 days prior to the start of packaging the Products and New Products.

Key Dates

Recommendation

The new food grade contract is a highly significant positive development for Flexible Solutions International, providing an estimated $6.5 million to $13 million in annual revenue to its subsidiary, Nanochem Solutions, Inc. Crucially, this revenue stream requires no additional capital expenditures, indicating immediate accretion to earnings and strong operational leverage. The five-year initial term with automatic renewals offers substantial long-term revenue visibility and stability. While the non-exclusive nature and customer's ownership of product IP are noted, the overall financial benefit, efficient asset utilization, and the company's strengthened position in a growing, regulated market segment make this a compelling investment case, warranting a 'strong buy' recommendation.

Keywords

Flexible Solutions International, Nanochem Solutions, Food Grade Contract, Manufacturing Agreement, Supply Agreement, Human Nutrition, SEC Filing, 8-K/A, Specialty Chemicals, Contract Manufacturing, FSI, NCS